Opening Speech delivered before about 400 participants (experienced professionals from Officers to Directors) on 14 Jan 2018 at ICCBS, University of Karachi (Pharmaceutical Manufacturing Dashboard 2017 Review)

1. Opening Note at Discussion Forum on Pharmaceutical Manufacturing Dashboard 2017 Review
(14th
Jan 2018 at ICCBS, University of Karachi)
Mrs. Roohi Bano Obaid
Deputy Director/ Civil Service Officer,
Drug Regulatory Authority, Government of Pakistan
Alumni, CDER Forum of International Regulators, US-FDA, Maryland
Alumni, HPFB Forum of International Regulators, Health Canada, Ottawa
Member International Society of Pharmaceutical Engineering (ISPE)
Member Parenteral Drug Association (PDA)
Indeed it is my great privilege to express our gratitude on behalf of CCK. Thank you very much for being with us,
for walking with us by great patience, for great enthusiasm to learn, and last but not the least for evolving visible
overwhelming spirits to support others. CCK is so gratified to see the extending coordination among participants and
extending volunteers engagements with us through CCK page on Facebook, through Google application and through
What’s App. You are aware that CCK does not charge any fee and all working behind is voluntary and free from
any financial interest. We leave it upon you to answer questions outside the CCK that why and how CCK is able to
do it. The beauty of discussions, its uniqueness, novelty and non-obviousness remains a source of energy and hope
among all of us Allhamdolilah.
Let me allow to share with you the recent death of our beloved Khalid Yousaf Sahab who always shared his
knowledge with generosity. He was a pharmacist by degree from Karachi University, studied further in USA and
was a registered pharmacist in USA till his death. He worked in Novartis for decades and we have very special
regards for him due to his contribution to the profession, affection and dignity. He will be deeply missed.
CCK has tried to provide opportunities of learning that may contribute in national progress. Like all other multiple
fields of science new innovations and technology in pharmacy and medicine seems to be committed to provide
treatment of disease like inherent diseases that may never be thought possible. Patients own immune cells are re-
engineered now to target their own cancer cells. Paradigm shift in every field is unpredictable. So the safety affairs
are much more challenging than ever before. On the other hand, the global world is encouraging generic competition
by reducing the potential misuse of scientific hitches to block entry of generic drugs, simplifying obstacles to
resolve scientific and regulatory concerns as well as reshaping the regulatory policy and framework in more
predictable and efficient way. Entry of generic products reduces prices and increase accessibility and its huge
contribution in healthcare system can never be undermined.
CCK is trying to provide both a platform and hope to our pharmaceutical circle for respecting the science and
discussion to achieve the best future and best contribution to the healthcare profession and society that would be
proven worthy for our generations. We understand the relationship between opportunities and progress but at the
same time we see deprivation proven as a great constituent of success. In any case, time is going fast, world is
becoming a global village and to live with grace we must not waste our time, we must not be rigid, we must not be
intolerant.
Our world has entered in a fast train that is designed with the ability to reshape its frames by default and align it with
the mission of protection and advancement of health. Our journey from gene therapy to biological intervention, from
multiple cycle review to smart review, from independence to interdependence, from traditional approach to risk
based approach, from science to super science, from truth to integrity, from hope to assurance in the business of
drug manufacturing is striding more progressively and smartly than ever before. About 04 new molecules per month
are coming out to reduce the disease burden and improve the quality of life and this speed have never been
witnessed in the history what we know.
Today we all will be taking part in great discussion that will remain focus on challenges, innovations and changes
this world is experiencing. We had decided in last meeting of CCK that we would dedicate the session with the
name of Khalid Yousuf Sahab, that’s why let me allow opening the Khalid Yousuf Sahab session of Dashboard
2017 Review. Have a very good day.